Literature DB >> 26207020

Four-Group Classification Based on Fibrinogen Level and Fibrin Polymerization Associated With Postoperative Bleeding in Cardiac Surgery.

Shingo Kawashima1, Yuji Suzuki2, Tsunehisa Sato3, Mutsuhito Kikura4, Takasumi Katoh1, Shigehito Sato1.   

Abstract

Fibrinogen and fibrin formation have a key role in perioperative hemostasis. The aim of this study is to examine the association of postoperative hemostasis with a combined evaluation of the fibrinogen level and fibrin polymerization in cardiac surgery. We retrospectively classified 215 consecutive cardiac surgery patients into 4 groups (Fuji-san classification) that were divided by fibrinogen level <150 mg/dL (ie, hypofibrinogenemia) and fibrinogen thromboelastometry value at 10 minutes with rotational thromboelastometry <6 mm (ie, low fibrin polymerization) at the warming of cardiopulmonary bypass. Four groups resulted; group I, the acceptable range (n = 85); group II, only hypofibrinogenemia (<150 mg/dL, ≥6 mm, n = 63); group III, hypofibrinogenemia and low fibrin polymerization (<150 mg/dL, <6 mm, n = 60); and group IV, only low fibrin polymerization (≥150 mg/dL, <6 mm, n = 7). The risk of chest tube drainage volume greater than 500 mL within the first 24 hours after surgery (with group I as the reference) was increased in group II (odds ratio [OR], 3.3; 95% confidence interval [CI], 1.5-7.4; P < .01) and group III (OR, 8.5; 95% CI, 3.5-21.7; P < .01), and the risk greater than 1000 mL (with group I as the reference) was increased in group III (OR, 4.0; 95% CI, 1.1-17.3; P = .03) and group IV (OR, 23.1; 95% CI, 3.2-201.0; P < .01). Intraoperative blood transfusions were decreased by 24.5%, after stratifying the starting amount of fresh frozen plasma by the 4-group classification in the recent consecutive 65 (30.2%) patients (P < .01). The 4-group classification is associated with postoperative bleeding and may improve the quality of perioperative blood transfusion in cardiac surgery.
© The Author(s) 2015.

Entities:  

Keywords:  blood coagulation; cardiac surgery; fibrinogen; hemostasis; thromboelastometry

Mesh:

Substances:

Year:  2015        PMID: 26207020     DOI: 10.1177/1076029615597061

Source DB:  PubMed          Journal:  Clin Appl Thromb Hemost        ISSN: 1076-0296            Impact factor:   2.389


  4 in total

1.  Thromboelastometry guided fibrinogen replacement therapy in cardiac surgery: a retrospective observational study.

Authors:  Francesco Vasques; Luca Spiezia; Alberto Manfrini; Vincenzo Tarzia; Dario Fichera; Paolo Simioni; Gino Gerosa; Carlo Ori; Guido Di Gregorio
Journal:  J Anesth       Date:  2016-10-18       Impact factor: 2.078

2.  The Impact of Thromboelastography on Blood Transfusion Policy in Adult Cardiac Surgery-A Retrospective Observational Study from Eastern India.

Authors:  Suvro Sankha Datta; Dibyendu De
Journal:  Indian J Hematol Blood Transfus       Date:  2020-06-23       Impact factor: 0.900

3.  A Low-dose human fibrinogen is not effective in decreasing postoperative bleeding and transfusion requirements during cardiac surgery in case of concomitant clinical bleeding and low FIBTEM values: A retrospective matched study.

Authors:  Iuliana-Marinela Lupu; Zineb Rebaine; Laurence Lhotel; Christine Watremez; Stéphane Eeckhoudt; Michel Van Dyck; Mona Momeni
Journal:  Ann Card Anaesth       Date:  2018 Jul-Sep

4.  Near-patient coagulation testing to predict bleeding after cardiac surgery: a cohort study.

Authors:  Andrew D Mumford; Jessica Harris; Zoe Plummer; Kurtis Lee; Veerle Verheyden; Barnaby C Reeves; Chris A Rogers; Gianni D Angelini; Gavin J Murphy
Journal:  Res Pract Thromb Haemost       Date:  2017-07-25
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.